medlogicai.org

Clinical intelligence. Better decisions.

Decision-Making Algorithm in Otorhinolaryngology & Head and Neck Surgery

Diagnosis & Management of Hoarseness & Dysphonia

Voice-first decision algorithm — airway / duration triage × voice-demand stratification × laryngoscopic & stroboscopic pivot × sixteen aetiology-keyed management pathways

Step 1

Step 1 of 6

Entry, Airway / Emergency Screen & Duration Triage

Define the voice complaint · screen for airway threat · split into acute (<2–3 weeks) vs chronic (>4 weeks) routes.

Hoarseness is a symptom, not a diagnosis. Patients present with a spectrum of voice complaints — change in quality, breathy voice, roughness, vocal fatigue, aphonia, loss of pitch range, reduced endurance, strained or strangled voice, intermittent voice breaks, globus, or singing limitation. The first task is to convert the complaint into one of two anatomic categories (true laryngeal vs functional) and into one of two temporal categories (acute vs chronic) — and to screen for airway threat at every step.

Airway emergency indicators — stridor, respiratory distress, rapid progression, severe dyspnoea, post-extubation distress, suspected bilateral vocal-fold immobility, large obstructing lesion, haemoptysis, severe aspiration — route to the emergency airway pathway (flexible laryngoscopy immediately, oxygen ± Heliox, nebulised adrenaline if indicated, ICU / anaesthesia activation, controlled airway planning with awake fibreoptic intubation, operative airway assessment, or tracheostomy as needed). See the parallel framework_red_flag and Acute Airway Obstruction chapter for the full algorithm.

Duration triage (see framework_duration_triage and the bespoke duration_triage_matrix). Acute dysphonia (<2–3 weeks) in an otherwise well patient is usually viral laryngitis, URI, acute phonotrauma, allergic / irritant exposure, or acute reflux — managed with voice conservation, hydration, vocal hygiene, and reflux precautions. Chronic dysphonia (>4 weeks) mandates complete laryngeal examination — no empirical management.

  • Define the voice complaint — quality · breathiness · roughness · pitch · endurance · breaks
  • Screen for airway emergency (stridor · distress · bilateral immobility · large lesion · haemoptysis)
  • Acute (<2–3 weeks) → conservative trial + reassess
  • Chronic (>4 weeks) → mandatory laryngeal visualization
  • Hoarseness >2–4 weeks is never treated empirically
  • Singers / professional voice users → earlier stroboscopy threshold

Key statistics

  • Empiric-management risk

    >2–4 weeks = always image

    Multiple national guidelines (AAO-HNSF, ENT-UK) converge on the rule that hoarseness persisting more than 2–4 weeks mandates laryngoscopy before any further treatment.

★ High-yield pearls (chapter-wide)

  • Hoarseness persisting more than 2–4 weeks ALWAYS requires laryngeal visualization — no chronic dysphonia is treated empirically.
  • The first decision in every hoarseness presentation is whether the airway is threatened — stridor / distress / bilateral fold immobility short-circuits the algorithm.
  • Videostroboscopy is essential for professional voice users, scar / sulcus, paresis, vascular lesions, and any subtle pathology — flexible laryngoscopy alone misses these.
  • Voice therapy is foundational — for most benign mid-membranous lesions, behavioural treatment alone resolves or prevents the need for surgery.
  • Unilateral leukoplakia in a smoker is dysplasia or carcinoma until proven otherwise — direct laryngoscopy + biopsy is mandatory.
  • Unilateral vocal-fold immobility demands imaging the entire vagus / RLN course — skull base to mediastinum (CT or MRI).
  • Vocal-fold haemorrhage is a phonotrauma emergency in the professional voice user — absolute voice rest, serial stroboscopy, no premature phonation.
  • Reflux is over-diagnosed and over-treated — empirical PPI in non-LPR dysphonia delays the real diagnosis and exposes the patient to long-course PPI risks.
  • Spasmodic dysphonia is speech-triggered laryngeal dystonia, not a functional disorder — botulinum-toxin injection is first-line, not voice therapy.
  • Phonomicrosurgery without prior stroboscopy is operating blind — the vibratory layer of Reinke's space is not visible on flexible laryngoscopy.

Evidence base

5 sources
  1. HIGH

    Stachler RJ et al. · Otolaryngology-Head and Neck Surgery · 2018National CPG (AAO-HNSF)PMID 29494321

    AAO-HNSF 2018 dysphonia CPG — canonical anchor for the duration-triage rule, red-flag screen, and the threshold for mandatory laryngoscopy in chronic dysphonia.

  2. HIGH

    Stachler RJ et al. · Otolaryngology-Head and Neck Surgery · 2018National CPG (AAO-HNSF)PMID 29494316

    Executive summary of the AAO-HNSF dysphonia CPG — distils the key action statements including the 4-week threshold beyond which empirical management is contraindicated.

  3. HIGH

    Krouse HJ et al. · Otolaryngology-Head and Neck Surgery · 2018National CPG (AAO-HNSF)PMID 29494315

    Patient-facing companion to the 2018 AAO-HNSF dysphonia CPG — reinforces the duration triage and timing of laryngoscopy for clinician-patient communication.

  4. MOD

    Roy N et al. · Journal of Speech, Language, and Hearing Research · 2004Cohort studyPMID 15157130

    Population-based prevalence study underpinning the AAO-HNSF estimate that dysphonia affects roughly one third of adults in their lifetime — justifies the triage burden at presentation.

  5. MOD

    Cohen SM et al. · Laryngoscope · 2012Cohort studyPMID 22544473

    U.S. claims-database analysis demonstrating the cost and care-utilization burden of dysphonia — supports the AAO-HNSF imperative to avoid empirical management of chronic hoarseness.

Decision tree

The airway / emergency screen is the first gate. Duration triage (acute <2–3 weeks vs chronic >4 weeks) is the second. For the chronic patient, laryngoscopy and stroboscopy findings route to one of sixteen pathways (A–P). The persistent-hoarseness-must-be-imaged rule and the silent-aspiration-of-voice (subtle paresis missed without stroboscopy) cross-cut every column.

Step 1 — Hoarseness / dysphonia → triageAirway emergency? (stridor · distress · bilateral immobility · large obstructing lesion · haemoptysis)Yes — emergencyNo — stableEmergency airway pathwayFlexible scope · O₂ ± Heliox · adrenaline · ICU / anaesthesia · awake fibreoptic / trachDuration of hoarseness?Acute <2–3 weeksChronic >4 weeksConservative trial + reassess at 2–4wVoice conservation · hydration · steam · vocal hygiene · NO empirical antibiotics · reassess; persistent → scopeMANDATORY laryngeal examination — flexible + stroboscopyInflammatory / mucosalPhonotrauma / vibratory layerStructural / mobilityOncologic / systemic / neuro / functionalInflammatory / mucosalPhonotrauma / vibratory layerStructural / mobilityOncologic · systemic · neuro · functionalAcute laryngitis (A)Diffuse oedema/erythema · conservative careLPR / posterior laryngitis (B)RSI / RFS · 8–12w PPI trial · de-escalate · lifestyleGranuloma / contact ulcer (K)Vocal-process lesion · reflux + voice tx · botox / excision if refractoryReinke's oedema (L)Smoker · polypoid distension · cessation + voice tx + reduction surgeryBenign mid-membranous lesions (C)Nodules · polyps · cysts — voice therapy first → phonomicrosurgeryVF haemorrhage (D)Performer · sudden voice loss · absolute rest · serial stroboscopyScar / sulcus vocalis (E)Reduced wave · stiffness · voice tx + augmentation · scar surgery selectiveVascular lesions (F)Varix · ectasia · recurrent haemorrhage → photoangiolysis (KTP / PDL)Presbyphonia / VF atrophy (G)Bowed cords · age ≥65 · voice therapy → injection / medialisationVF paresis / paralysis (H)Unilateral or bilateral · image RLN course · injection / type I / reinnervationMalignancy / dysplasia (I)Leukoplakia · ulceration · smoker · DL + biopsy · oncology MDTPapillomatosis / RRP (J)HPV 6/11 · multiple exophytic · debulking · adjuvant cidofovir / bevacizumabRheumatologic / autoimmune (M)RA · GPA · sarcoid · amyloid · rheumatology + medical control firstNeurogenic dysphonia (N)PD / ALS / MG / tremor · neurology + LSVT-LOUD + targeted therapySpasmodic dysphonia (O)Task-specific spasm · BOTOX first-line (TA adductor / PCA abductor)Functional / MTD (P)Normal wave · supraglottic squeeze · voice therapy primary · psychology if psychogenicPersistent hoarseness >2–4 weeks — NEVER treat empirically · always laryngoscope→ Mandatory complete laryngeal examination + stroboscopy where availableProfessional voice user — singer · teacher · broadcaster · lawyer · religious speaker→ Earlier stroboscopy · singing-voice assessment · lower threshold for interventionTreatment escalation ladder — apply across every pathway→ Hygiene · medical · voice therapy · office procedure · phonomicrosurgery · framework surgery · MDTPathways:A Acute laryngitisB LPRC Benign mid-mbD HaemorrhageE Scar/sulcusF VascularG PresbyphoniaH Paresis/paralysisI MalignancyJ PapillomatosisK GranulomaL ReinkeM RheumatologicN NeurogenicO SpasmodicP MTD
Step 1

Disclaimer

For educational purposes only. Not for clinical use. This platform is an instructional resource intended to support learning about clinical decision-making and the interpretation of investigations. Clinicians remain completely responsible for the interpretation of findings, the formulation of a differential diagnosis, and any clinical decision. Nothing in this application replaces individualized assessment, hands-on training, expert consultation, or established practice guidelines.

Not for profit effort by

Dr. Prahlada N.B

  • MBBS (JJMMC), MS (PGIMER, Chandigarh)
  • MBA in Hospital & Healthcare Management (BITS, Pilani)
  • Postgraduate Certificate in Technology Leadership and Innovation (MIT, USA)
  • Executive Programme in Strategic Management (IIM, Lucknow)
  • Senior Management Programme in Healthcare Management (IIM, Kozhikode)
  • Advanced Certificate in AI for Digital Health and Imaging Program (IISc, Bengaluru)

Supporting organisations

  • Karnataka ENT Hospital and Research Centre (R)
  • Champions Educational and Medical Society (R)
  • Amogh Foundation